Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DR26FJMY2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,865
Award facts
- Contract value 100% obligated
- $19,865.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on January 12, 2026, for Entyvio 300 mg vials, with a ceiling value of $19,865.04 and an ultimate completion date of January 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is priced firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FJMY2?
SPE2DR26FJMY2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FJMY2 worth?
The government has obligated $19,865 on SPE2DR26FJMY2.
Is contract SPE2DR26FJMY2 an order under another contract?
Yes. SPE2DR26FJMY2 is a delivery order under SPE2DR25D9644, an indefinite delivery contract.
Was contract SPE2DR26FJMY2 competed?
The extent of competition for SPE2DR26FJMY2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award